Botanical species · safety record

Isocoma pluriflora

The EFSA Compendium of Botanicals holds 14 constituent measurements and 4 adverse-effect records for Isocoma pluriflora. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Isocoma pluriflora (Torr. & A.Gray) Greene

14Constituent measurements
4Safety records
5Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • 3-oxyangeloyl-tremetone4
  • Dehydrotremetone4
  • Tremetone4
  • Benzofurans1
  • Carvone1

Plant parts

  • Aerial part of plants9
  • Live plants5

Preparations

  • Solvent extraction14

Effect types

  • Pulmonary and cardiac3
  • Musclo-skeletal1

Target tissues

  • Heart3
  • Muscle, skeletal1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
3-oxyangeloyl-tremetoneAerial part of plantsSolvent extraction≥ 1.9 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
3-oxyangeloyl-tremetoneAerial part of plantsSolvent extraction≤ 4 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
3-oxyangeloyl-tremetoneAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
3-oxyangeloyl-tremetoneLive plantsSolvent extraction2.39 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DehydrotremetoneLive plantsSolvent extraction1.34 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DehydrotremetoneAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DehydrotremetoneAerial part of plantsSolvent extraction≤ 2.6 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DehydrotremetoneAerial part of plantsSolvent extraction≥ 0.8 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
TremetoneLive plantsSolvent extraction0.53 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
TremetoneAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
TremetoneAerial part of plantsSolvent extraction≤ 0.4 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
TremetoneAerial part of plantsSolvent extraction≥ 0.16 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
BenzofuransLive plantsSolvent extractionChromatographic testsNo resolvable identifier
CarvoneLive plantsSolvent extractionChromatographic testsNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Musclo-skeletalMuscle, skeletalGoat (as animal)Short-term toxicityResolve DOI
Pulmonary and cardiacHeartHorse (as animal)Short-term toxicityResolve DOI
Pulmonary and cardiacHeartGoat (as animal)Short-term toxicityResolve DOI
Pulmonary and cardiacHeartHorse (as animal)Short-term toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Zalkow, L. H., Ekpo, B. A., Gelbaum, L. T., Harris, R. N., III., Keinan, E., Novak, J. R., Jr., Ramming, C. T., Van Derveer, D. The benzofurans of Isocoma wrightii. Structure and stereochemistry. Journal of Natural Products, 1979, p. 203-219.
  2. Davis, T. Z., Stegelmeier, B. L., Lee, S. T., Green, B. T., Hall, J. O. Experimental rayless goldenrod (Isocoma pluriflora) toxicosis in horses. TOXICON, 2013, vol. 73, p. 88-95. DOI
  3. Davis, T. Zane., Green, Benedict T., Stegelmeier, Bryan L., Lee, Stephen T., Welch, Kevin D., Pfister, James A. Physiological and serum biochemical changes associated with rayless goldenrod (Isocoma pluriflora) poisoning in goats. TOXICON, 2013, vol. 76, p. 247-254. DOI
  4. Lee, Stephen T., Cook, Daniel., Davis, T. Zane., Gardner, Dale R., Johnson, Robert L., Stonecipher, Clinton A. A Survey of Tremetone, Dehydrotremetone, and Structurally Related Compounds in Isocoma spp. (Goldenbush) in the Southwestern United States . Journal of agricultural and food chemistry, 2015, vol. 63, no. 3, p. 872-879. DOI
  5. Zalkow, L.H., Harris III, R.N., Burke, N.I. The lower terpenoids of Isocoma Wrightii. Journal of Natural Products, 1979, p. 96-102.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue